Role of ceramides in the pathogenesis of diabetes mellitus and its complications
- 16 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 35 (2) , 107734
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 189 references indexed in Scilit:
- Role of ceramide in diabetes mellitus: evidence and mechanismsLipids in Health and Disease, 2013
- Ceramide synthases at the centre of sphingolipid metabolism and biologyBiochemical Journal, 2012
- Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytesKidney International, 2011
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceNature Medicine, 2011
- Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectinNature Medicine, 2010
- Kdo2-Lipid A, a TLR4-specific Agonist, Induces de Novo Sphingolipid Biosynthesis in RAW264.7 Macrophages, Which Is Essential for Induction of AutophagyJournal of Biological Chemistry, 2010
- An Introduction to Sphingolipid Metabolism and Analysis by New TechnologiesNeuroMolecular Medicine, 2010
- Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway ConformersJournal of Biological Chemistry, 2010
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- The sphingolipid salvage pathway in ceramide metabolism and signalingCellular Signalling, 2008